Machine Translation utilizes computational biology, novel Machine Learning & AI, bioinformatic simulations, and a unique data set to determine which drug candidates will most likely succeed in clinical studies.

Machine Translation

Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

William Goddard

Richard Friesner

Schrödinger, Inc.

Akorbi provides advanced language technology platforms and services to help businesses expand their global reach by facilitating communication across different languages and cultures.

Akorbi

Alpha CRC offers localization services that help clients reach their international consumer base, engage with them locally, and enable workflow innovation. Self-described as tech-enabled localization.

Metric
Company Name	Machine Translation	Schrödinger, Inc.	Akorbi	Alpha CRC
Symbol		SDGR
MSH ID	COM:MACHTRANSPRO	COM:SCHRODINGER	COM:AKORBI	COM:ALPHACRC
Market	PRIVATE	STOCKS	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare	Commercial & Professional Services	Commercial & Professional Services
Industry	Biotechnology	Medical - Healthcare Information Services	Language Services	Translation and Localization
Country	US	US	US	GB
Stage
Employee Count		867
Website	machtranspro.com	schrodinger.com	akorbi.com	alphacrc.com
LinkedIn			akorbi	alpha-crc
Founders

Metric
Market Cap		1.50B
Enterprise Value
Monthly Web Traffic	162.88K	94.03K	118.76K
Web Traffic Growth	-0.34	0.10	0.95
Valuation
Raised Capital		10M

Metric
Revenue		216.67M
Revenue (LTM)
Revenue (NTM)
Gross Profit		140.10M
EBITDA		-171.90M
Operating Income		-177.45M
Net Income		40.72M
EPS		0.57
Diluted EPS		0.54
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin		0.66
Operating Profit Margin		-0.82
EBITDA Margin		-0.79
Net Profit Margin		0.19
Return on Equity		0.07
Return on Assets		0.05
Return on Capital Employed		-0.27

MACH

COM:MACHTRANSPRO

Machine Translation

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio		42.57
P/B Ratio		3.34
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio		12.15
EV Multiple		-5.56

Metric
Days Sales Outstanding		58.83
Days Payables Outstanding		48.57
Days Inventory Outstanding		0.00
Operating Cycle		150.13
Cash Conversion Cycle		69.34
Asset Turnover		0.29

Metric
Operating Cash Flow		10.48M
Free Cash Flow		-2.92M
Cash Flow to Debt		-1.07
Operating Cash Flow/Sales		-0.63
Free Cash Flow Yield		-0.07

Metric
Cash & Equivalents		161.07M
Accounts Receivable		-20.03M
Inventory
Goodwill		4.79M
Debt to Capitalization		0.21
Debt to Assets		0.16
Current Ratio		5.21
Quick Ratio		4.64

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue		0.23
R&D to Revenue		0.83
SG&A to Revenue		0.49